Routine accounting officer appointment — no material read-through for operations or strategy. Monitor future filings for any financial reporting developments, but this filing alone does not warrant a trading response.
Price Chart
Executive Summary
Altimmune appointed Richard Menziuso as Vice President, Global Controller and Principal Accounting Officer, effective September 29, 2026. CFO Gregory Weaver remains in place. This is a routine senior accounting hire with no financial data or strategic implications.
Key Facts
- Richard Menziuso appointed VP, Global Controller and Principal Accounting Officer effective September 29, 2026.
- CFO Gregory Weaver remains in place — no departure or change.
- Menziuso brings 28 years of finance/accounting experience, most recently as VP Corporate Controller at Centessa Pharmaceuticals until its 2026 acquisition by Eli Lilly.
- Standard indemnification agreement to be entered, consistent with other executive officers.
Financial Impact
No financial figures disclosed — routine appointment with no material financial impact.
Risk Factors
- No material risks identified — filing is administrative in nature.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001326190-26-000056 |
| Document: 0001326190-26-000056-index-headers.html | 0001326190-26-000056 |
| Document: 0001326190-26-000056-index.html | 0001326190-26-000056 |
| Document: 0001326190-26-000056.txt | 0001326190-26-000056 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 29, 2026 27d ago | 8-K | $2.97 $2.67 | ▼ −10.10% | ▼ −12.05% | $2.09 (−29.63%) |
Aug 12, 2026 10w ago | 8-K | $2.93 $3.12 | ▲ +6.48% | ▲ +6.93% | $2.09 (−28.67%) |
Aug 12, 2026 10w ago | Press Release | $2.93 $3.12 | ▲ +6.48% | ▲ +6.93% | $2.09 (−28.67%) |
Aug 6, 2026 11w ago | Institutional Cluster | $3.01 $2.88 | ▼ −4.32% | ▼ −5.53% | $2.09 (−30.56%) |
Aug 5, 2026 11w ago | Press Release | $3.03 $2.93 | ▼ −3.30% | ▼ −3.65% | $2.09 (−31.02%) |
Aug 3, 2026 12w ago | Press Release | $3.00 $3.05 | ▲ +1.67% | ▼ −0.36% | $2.09 (−30.33%) |
Jul 28, 2026 12w ago | 8-K | $2.99 $3.00 | ▲ +0.33% | ▼ −1.93% | $2.09 (−30.10%) |
May 28, 2026 21w ago | Press Release | $3.07 $2.87 | ▼ −6.51% | ▼ −6.47% | $2.09 (−31.92%) |
May 27, 2026 21w ago | Press Release | $2.98 $2.90 | ▼ −2.68% | ▼ −3.89% | $2.09 (−29.87%) |
May 13, 2026 23w ago | 8-K | $3.02 $2.74 | ▼ −9.27% | ▼ −8.11% | $2.09 (−30.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers